Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Â Aligos Therapeutics, Inc. (Nasdaq: ALGS, âAligosâ, âCompanyâ), a clinical stage biopharmaceutical company focused on improving pati...